Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 1, Issue 3, Pages 198-210Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd746
Keywords
-
Ask authors/readers for more resources
Cell-surface receptors are the targets for more than 60% of current drugs. Traditionally, optimizing the interaction of lead molecules with the binding site for the endogenous agonist (orthosteric site) has been viewed as the best means of achieving selectivity of action. However, recent developments have highlighted the fact that drugs can interact with binding sites on the receptor molecule that are distinct from the orthosteric site, known as allosteric sites. Allosteric modulators could offer several advantages over orthosteric ligands, including greater selectivity and saturability of their effect.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available